$INSM
SEC EDGAR Filings Hub
2 Filings
$INSM · INSMED Inc SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for INSMED Inc ($INSM) from October 29, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $INSM portfolio concentration →
View $INSM Congress trades →
Research $INSM stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports1
8-K Material Events1
Form 4 Insider0
High-Impact2
Latest FilingOctober 29, 2026
Browse SEC Filings by Form Type
Latest $INSM SEC Filings & AI Summaries (2)
October 29, 2026
$INSM 10-Q — INSMED Inc
Insmed's BRINSUPRI is delivering one of the strongest rare-disease launches in recent biotech history, with revenue nearly quadrupling YoY and the company approaching operating…
October 29, 2026
$INSM 8-K — INSMED Inc
BRINSUPRI is tracking toward a >$1.3B first-full-year launch, one of the strongest rare-disease drug debuts ever, with peak sales guided above $7B.